European Healthtech startup funding raised during 2026.
In 2026, 238 European Healthtech companies raised a combined €4.4B across 242 funding rounds. UK led by capital raised, and High-Tech Gründerfonds (HTGF) was the most active investor. Data as of 6 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Isomorphic Labs | Series B | May 2026 | €1.8B |
| Oviva | Series D+ | Jan 2026 | €200M |
| Alvotech | Debt | Jan 2026 | €100M |
| CeQur | Series D+ | Jun 2026 | €86M |
| Ona Therapeutics |
| Series B |
| Jun 2026 |
| €74M |
| DentalMonitoring | Other | Feb 2026 | €71M |
| Neurent Medical | Series C | Feb 2026 | €63M |
| Vitestro | Series B | Mar 2026 | €60M |
| Uromems | Growth/Late | May 2026 | €52M |
| Exciva | Series B | Jan 2026 | €51M |
| FineHeart | Grant | Jan 2026 | €48M |
| Storm Therapeutics | Series C | Apr 2026 | €48M |
| NVision Imaging | Series B | May 2026 | €47M |
| IMU Biosciences | Other | Jun 2026 | €45M |
| Biorce | Series A | Feb 2026 | €44M |
